Filing Flows

Filing Flows › Companies › Health Catalyst › Cash flow

Health Catalyst cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$2.0M in Q3 2026 · $25.7M over twelve months

Operating cash flow−$1.9M
Capital spending−$156K
Free cash flow−$2.0M
Cash / net income-0.0×
Cash conversion cycle47 days

Analysis

In Q3 2026, Health Catalyst generated −$1.9M of operating cash flow and spent $156K on capital projects, leaving free cash flow of −$2.0M. That is $1.3M less than in Q3 2025 (−$719K).

Over the twelve months to Sep 30, 2026, operating cash flow was $26.8M; the largest uses were other financing ($164M), capital spending ($1.1M); besides operations, cash came from other investing ($151M), shares issued ($602K); the cash balance rose by $13.4M.

Operating cash flow was −$1.9M against net income of $40.5M — -0.0× profit, less cash than reported earnings, worth checking against working capital. The largest differences: depreciation & amortization +$9.7M, stock-based pay +$4.1M, prepaid and other assets +$1.2M.

Its cash conversion cycle was 47 days (receivables 68 + inventory 0 − payables 21).

Free cash flow

Health Catalyst: free cash flow by quarterHealth Catalyst: free cash flow by quarter−$3.9MQ4 2024−$390KQ1 2025−$8.8MQ2 2025−$719KQ3 2025$9.6MQ4 2025$18.2MQ1 2026−$70KQ2 2026−$2.0MQ3 2026
Operating cash flow less capital spending.
Health Catalyst: operating cash flow against capital spendingHealth Catalyst: operating cash flow against capital spendingOperating cash flowCapital spending−$3.5M$413KQ4 2024$280K$670KQ1 2025−$9.0M−$230KQ2 2025−$464K$255KQ3 2025$9.9M$273KQ4 2025$18.5M$338KQ1 2026$275K$345KQ2 2026−$1.9M$156KQ3 2026
Latest (Q3 2026): Operating cash flow −$1.9M, Capital spending $156K.

Capital allocation, year by year

Health Catalyst: where the cash came from (up) and went (down), by fiscal yearHealth Catalyst: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksFY2021: Operating cash flow −$23.1MFY2021: Shares issued $266MFY2021: Asset sales $22KFY2021: Capital spending −$10.4MFY2021: Acquisitions −$46.8M$266MFY2021FY2022: Operating cash flow −$35.3MFY2022: Shares issued $4.0MFY2022: Asset sales $29KFY2022: Capital spending −$2.2MFY2022: Acquisitions −$27.8MFY2022: Buybacks −$8.4M$4.0MFY2022FY2023: Operating cash flow −$33.1MFY2023: Shares issued $950KFY2023: Asset sales $31KFY2023: Capital spending −$1.2MFY2023: Acquisitions −$11.4MFY2023: Buybacks −$1.8M$981KFY2023FY2024: Operating cash flow $14.6MFY2024: Net borrowing $151MFY2024: Shares issued $169KFY2024: Asset sales $13KFY2024: Capital spending −$1.6MFY2024: Acquisitions −$80.3M$166MFY2024FY2025: Operating cash flow $731KFY2025: Asset sales $44KFY2025: Capital spending −$968KFY2025: Acquisitions −$41.1MFY2025: Buybacks −$5.0M$775KFY2025
Over these 5 years operating cash flow totalled −$76.2M; the largest uses were acquisitions ($207M) and operating cash flow ($91.5M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$79.0M
Debtnone
Net cash$79.0M
Due within a year$1.6M

Health Catalyst funds itself: free cash flow was $25.7M over the last twelve months, with $79.0M of cash and investments and no debt on the balance sheet ($1.6M due within a year, 48.6× covered by cash).

Health Catalyst: debt maturities by year (FY2025)Health Catalyst: debt maturities by year (FY2025)$1.6MYear 1$1.6MYear 2$1.6MYear 3$156MYear 4
Principal due in each year as disclosed in the annual report, against $79.0M of cash and investments now.

Where the cash came from and went

Health Catalyst: sources (+) and uses (−) of cash, Q3 2026Health Catalyst: sources (+) and uses (−) of cash, Q3 2026Other financing−$163MOther investing$158MCash drawn (+) / kept (−)$6.8MOperating cash flow−$1.9MShares issued$269KCapital spending−$156KExchange rates$23KAsset & business sales$11K
Health Catalyst: sources (+) and uses (−) of cash, TTM to Q3 2026Health Catalyst: sources (+) and uses (−) of cash, TTM to Q3 2026Other financing−$164MOther investing$151MOperating cash flow$26.8MCash drawn (+) / kept (−)−$13.4MCapital spending−$1.1MShares issued$602KAsset & business sales$39KExchange rates−$8K

From profit to cash

Health Catalyst: net income to operating cash flow, Q3 2026Health Catalyst: net income to operating cash flow, Q3 2026Net income$40.5MDepreciation & amortization$9.7MStock-based pay$4.1MDeferred taxes−$334KReceivables−$317KDeferred revenue$309KPrepaid and other assets$1.2MOperating cash flow−$1.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 202668—2147
Q2 202665—2640
Q1 202675—2748
Q4 202573—1955
Q3 202577—1761
Q2 202575—1955
Q1 202569—2147
Q4 202463—2637

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026−$1.9M−$156K———$269K$6.8M−$2.0M
Q2 2026$275K−$345K———−$43K−$725K−$70K
Q1 2026$18.5M−$338K———$403K−$9.1M$18.2M
Q4 2025$9.9M−$273K————−$10.5M$9.6M
Q3 2025−$464K−$255K————$10.4M−$719K
Q2 2025−$9.0M$230K$8K———$291M−$8.8M
Q1 2025$280K−$670K−$41.1M−$5.0M——−$92.3M−$390K
Q4 2024−$3.5M−$413K−$25.4M—$36.8M—$78.7M−$3.9M

Health Catalyst: income statement and cash flow

Health Catalyst, Q3 2026: revenue $56.3M (-26% year over year), operating margin 89.1%. The chart follows the revenue to costs, profit and cash.

Health Catalyst: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.